Oligonucleotides as the basis of gene-targeted therapeutic drugs

[1] BELIKOVA AM, 1967, TETRAHEDRON LETT, P3357

[2] Interaction of LNA oligonucleotides with MDR1 promoter [J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) : 847 - 850

[3] Silence of the strands: RNA interference in eukaryotic pathogens [J]. TRENDS IN MICROBIOLOGY, 2003, 11 (01) : 37 - 43

[4] Crooke ST, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P1

[5] Analysis of gene function in somatic mammalian cells using small interfering RNAs [J]. METHODS, 2002, 26 (02) : 199 - 213

[6] The MYC Oncogene as a Cancer Drug Target [J]. CURRENT CANCER DRUG TARGETS, 2003, 3 (03) : 163 - 175

[7] KABILOVA TO, 2004, IN PRESS NUCLEOSIDES

[8] 5′-bis-pyrenylated oligonucleotides displaying excimer fluorescence provide sensitive probes of RNA sequence and structure [J]. NUCLEIC ACIDS RESEARCH, 2001, 29 (17) : 3611 - 3620

[9] LOGASHENKO EV, 2004, IN PRESS FEBS LETT

[10] LOGASHENKO EV, 2004, IN PRESS NUCLEOTIDES

[1] BELIKOVA AM, 1967, TETRAHEDRON LETT, P3357

[2] Interaction of LNA oligonucleotides with MDR1 promoter [J]. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) : 847 - 850

[3] Silence of the strands: RNA interference in eukaryotic pathogens [J]. TRENDS IN MICROBIOLOGY, 2003, 11 (01) : 37 - 43

[4] Crooke ST, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P1

[5] Analysis of gene function in somatic mammalian cells using small interfering RNAs [J]. METHODS, 2002, 26 (02) : 199 - 213

[6] The MYC Oncogene as a Cancer Drug Target [J]. CURRENT CANCER DRUG TARGETS, 2003, 3 (03) : 163 - 175

[7] KABILOVA TO, 2004, IN PRESS NUCLEOSIDES

[8] 5′-bis-pyrenylated oligonucleotides displaying excimer fluorescence provide sensitive probes of RNA sequence and structure [J]. NUCLEIC ACIDS RESEARCH, 2001, 29 (17) : 3611 - 3620

[9] LOGASHENKO EV, 2004, IN PRESS FEBS LETT

[10] LOGASHENKO EV, 2004, IN PRESS NUCLEOTIDES